… Mortality from lung and ovarian cancer … lung and ovarian cancer mortality for the current
follow-up period. It is also of interest to examine all deaths, excluding those from the trial cancers. …

… of PSA screening is to reduce mortality from prostate cancer, … of the 3 screening trials was
prostate cancer mortality.2-5 … of the effect of PSA screening on metastatic prostate cancer in …

… of data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, a large …
evaluate colorectal cancer incidence, disease-specific mortality, and all-cause mortality based …

… this trial to establish the effect of early detection by screening on ovarian cancer mortality. …
component of the Prostate Lung Colorectal Ovarian (PLCO) Cancer Screening Trial. The …

… in the PLCO trial for both incidence and mortality by several years, allowing the assessment
of longer-term effects of screening. With respect to incidence, in addition to assessing overall …

… cancers in an earlier stage in the multimodal screening group. This analysis concluded that
screening women at an average risk of ovarian cancer … to predict ovarian cancer mortality in …

… of screen-detected ovarian abnormalities. Criteria for ovarian abnormality on TVU vary from
one screening … ovarian tumor or a solid ovarian tumor with an abnormally increased volume. …

… Pertinent exclusion criteria for this study were individuals with a history of CRC or lung,
prostate, or ovarian cancer, previous surgical removal of the colon, lung, or prostate, or, starting …

… of prostate, lung, colorectal, and ovarian cancer. Participants were randomized to screening
vs… Furthermore, there was no effect of screening for other cancers (prostate, colon, lung, and …

… control group at 10 screening centers from November 8, … prostate, lung, colorectal, or ovarian
cancer; undergoing treatment for cancer (except for basal or squamous cell skin carcinoma…